Erica Jordan insider trades
Open-market stock purchases and sales by Erica Jordan, Chief Commercial Officer at Revance Therapeutics, Inc, from SEC Form 4 filings since Apr 16, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- RVNC Revance Therapeutics, Inc: 1 sale, last Feb 6, 2025